INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
Go back to INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||
| (NASDAQ: INMB) | Delayed: 2.44 +0.17 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.45 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 323,962 | |||||

